Scientists test 'Living Drug' to reset immune system in 8 serious diseases
NCT ID NCT06548620
Summary
This early-phase study aimed to test a new type of cell therapy for people with serious autoimmune diseases like lupus, multiple sclerosis, and myasthenia gravis. The therapy, called CAR-T, involves modifying a patient's own immune cells to target and remove the cells causing the body to attack itself. The goal was to see if this approach was safe and could help control these difficult conditions, but the trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 461499, China
Conditions
Explore the condition pages connected to this study.